July 28, 2026

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: 15.45% Potential Upside Awaits Investors

Kymera Therapeutics, Inc. (NASDAQ: KYMR) stands out in the biotechnology sector with its innovative approach to developing small molecule therapeutics that degrade disease-causing proteins. Headquartered in Watertown, Massachusetts, this clinical-stage..

Addus HomeCare Corporation (ADUS) Stock Analysis: Strong Buy Ratings and 15% Upside Potential

Addus HomeCare Corporation (NASDAQ: ADUS) is capturing investor attention with its robust position in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $2.16..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring Nearly 100% Potential Upside

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company specializing in treatments for rare and ultra-rare genetic diseases, presents an intriguing opportunity for investors, boasting a potential upside of nearly 98.47%..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: A Biotech Powerhouse with 57% Potential Upside

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a key player in the biotechnology sector specializing in eye care therapeutics, has captured the attention of the investment community with its impressive growth prospects..

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Innovator with 21% Upside Potential

For investors keen on the healthcare sector, particularly the cutting-edge world of biotechnology, Scholar Rock Holding Corporation (NASDAQ: SRRK) offers a compelling opportunity. With a market capitalization of $5.86 billion,..

GeneDx Holdings Corp. (WGS) Stock Analysis: A 35% Potential Upside in the Diagnostics Sector

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the healthcare sector specializing in diagnostics and research, is positioning itself as a compelling opportunity for investors seeking exposure to the..

Warby Parker Inc. (WRBY) Stock Analysis: Potential 21% Upside Beckons Investors

Warby Parker Inc. (NYSE: WRBY) stands as a distinctive player in the healthcare sector, specifically within the medical instruments and supplies industry. Known for revolutionizing the eyewear market with its..

Vericel Corporation (VCEL) Stock Analysis: A Biotech Powerhouse with 26% Potential Upside

Vericel Corporation (NASDAQ: VCEL) is making waves in the biotechnology sector, particularly within the niche markets of sports medicine and burn care. This commercial-stage biopharmaceutical company, headquartered in Burlington, Massachusetts,..

CG Oncology, Inc. (CGON) Stock Analysis: Exploring a 23% Upside Potential in Biotech Innovation

CG Oncology, Inc. (NASDAQ: CGON) stands at the forefront of innovation in the biotechnology sector, focusing on the development of groundbreaking therapies for bladder cancer. With a market capitalization of..

Envista Holdings (NVST) Stock Analysis: A Healthcare Gem with a 10.47% Upside Potential

Envista Holdings Corporation (NYSE: NVST), a prominent player in the healthcare sector, specializes in the development and sale of dental products, offering a diverse portfolio under well-recognized brands like Nobel..

Ardent Health, Inc. (ARDT) Stock Analysis: A Healthcare Contender with 10% Upside Potential

Ardent Health, Inc. (NYSE: ARDT), a prominent player in the healthcare sector, has caught the attention of investors with its robust growth trajectory and potential upside. With a market capitalization..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Unpacking the 28% Potential Upside for Investors

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM), a biopharmaceutical firm based in Foster City, California, is making waves in the healthcare sector with its focus on therapies for rare and orphan diseases...

Harmony Biosciences Holdings, Inc. (HRMY) Stock Analysis: Exploring a 26% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a dynamic player in the biotechnology sector, presents a compelling case for investors with its focus on innovative therapies for rare neurological diseases. Headquartered..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A High Potential Play with 33.49% Upside

Alignment Healthcare, Inc. (NASDAQ: ALHC), a prominent player in the healthcare plans industry, is capturing investor attention with its impressive growth trajectory and substantial upside potential. The company, founded in..

ICU Medical, Inc. (ICUI) Stock Analysis: Potential Upside and Buy Ratings Make It a Healthcare Contender

ICU Medical, Inc. (NASDAQ: ICUI) stands at a pivotal juncture in the healthcare sector, presenting an intriguing opportunity for investors. With a market capitalization of $4.04 billion, this U.S.-based company..

CRISPR Therapeutics AG (CRSP)

⚠️ No article content returned.

..

Perrigo Company plc (PRGO) Stock Analysis: Exploring a Potential 62.72% Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO), a key player in the healthcare sector specializing in over-the-counter health and wellness solutions, offers investors an intriguing opportunity, particularly with its potential upside of..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: Navigating a High-Stakes Biotech Landscape with Uncertain Yet Promising Clinical Trials

Apogee Therapeutics, Inc. (NASDAQ: APGE), a burgeoning name in the biotechnology sector, is captivating investor attention with its ambitious pipeline of biologics aimed at combating a range of inflammatory and..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A 23% Potential Upside in the Biotech Sector

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a key player in the biotechnology sector, is making waves with its focus on neurological and psychiatric disorders. The Canadian-based company currently boasts a market..

Concentra Group Holdings (CON) Stock Analysis: A Healthcare Leader with 4.66% Upside

Concentra Group Holdings Parent, Inc. (NASDAQ: CON), a prominent player in the healthcare sector, primarily focuses on providing occupational health services across the United States. With a market capitalization of..

Search

Funds

July 28, 2026

Search

Funds

July 28, 2026

FTSE 100

Funds